⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3857957 | 0.72 | — | — | |
| SCHEMBL3857959 | 0.72 | — | — | |
| SCHEMBL125738 | 0.67 | — | — | |
| Hydrogen Sulfide SCHEMBL10809945 | 0.62 | — | — | |
| SCHEMBL3931 | 0.61 | — | — | |
| SCHEMBL4360702 | 0.61 | — | — | |
| SCHEMBL368417 | 0.58 | — | — | |
| Butadiene SCHEMBL43684 | 0.55 | — | — | |
| Butadiene SCHEMBL2933701 | 0.55 | — | — | |
| Butadiene SCHEMBL28451 | 0.55 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 138 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113699117-B | Use of genetically engineered oligodendrocyte progenitor cells in multiple sclerosis | 呈诺再生医学科技(北京)有限公司 | 2023-06-30 | — | — | CN | claimed |
| WO-2023030489-A1 | APPLICATION OF GENETICALLY MODIFIED OLIGODENDROCYTE PROGENITOR CELL IN MULTIPLE SCLEROSIS | 呈诺再生医学科技(北京)有限公司 | 2023-03-09 | — | — | WO | claimed |
| CN-113699117-A | Application of genetically modified oligodendrocyte progenitor cells in multiple sclerosis | 呈诺再生医学科技(北京)有限公司 | 2021-11-26 | — | — | CN | claimed |
| EP-3271469-A1 | ENZYMATIC PRODUCTION OF GLYCOSYLATED SYNTHONS | Institut National De La Recherche Agronomique (INRA) (FR) | 2018-01-24 | — | — | EP | claimed |
| WO-2016146764-A1 | ENZYMATIC PRODUCTION OF GLYCOSYLATED SYNTHONS | INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE (INRA) (FR) | 2016-09-22 | — | — | WO | claimed |
| US-20160251613-A1 | CULTURE METHOD FOR PLURIPOTENT STEM CELLS, CULTURE KIT, AND MEDIUM FOR PLURIPOTENT STEM CELL CULTURE | FUJIFILM CORPORATION (JP) | 2016-09-01 | — | — | US | claimed |
| EP-1434789-B1 | IMPROVED PROTEIN DISAGGREGATION AND REFOLDING USING HIGH PRESSURE | BAROFOLD INC (US) | 2008-03-26 | — | — | EP | claimed |
| WO-2007106435-A2 | CLEAVABLE VACCINES COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME | UNIVERSITY OF CALIFORNIA (US) | 2007-09-20 | — | — | WO | claimed |
| WO-2024116183-A1 | METHODS FOR DECELLULARIZING HUMAN OMENTUM AND PRODUCTS GENERATED THEREFROM | MATRICELF LTD. (IL) | 2024-06-06 | — | — | WO | disclosed |
| US-20240093148-A1 | METHOD FOR DIFFERENTIATING HUMAN INDUCED PLURIPOTENT STEM CELLS INTO OLIGODENDROCYTES, AND KIT AND USE | ALLIFE MEDICINE (ZHUHAI) LIMITED (CN) | 2024-03-21 | — | — | US | disclosed |
| EP-4282972-A2 | PRODUCTION OF BRANCHED CHAIN FATTY ACIDS AND DERIVATIVES THEREOF IN RECOMBINANT MICROBIAL CELLS | Genomatica, Inc. (US) | 2023-11-29 | — | — | EP | disclosed |
| EP-4276097-A1 | AMINOPYRIMIDINYL DERIVATIVES FOR THE TREAMENT OF PARKINSON'S DISEASE | University Of Dundee (GB) | 2023-11-15 | — | — | EP | disclosed |
| EP-3497231-B1 | BACTERIAL SYSTEMS FOR ANALYZING UBIQUITYLATED POLYPEPTIDES | TECH INNOVATION MOMENTUM FUND ISRAEL LIMITED PARTNERSHIP (IL) | 2023-10-04 | — | — | EP | disclosed |
| CN-113699117-B | Use of genetically engineered oligodendrocyte progenitor cells in multiple sclerosis | 呈诺再生医学科技(北京)有限公司 | 2023-06-30 | — | — | CN | disclosed |
| EP-0435617-A1 | Bovine myogenic factor gene | THE UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 1991-07-03 | — | — | EP | disclosed |
| WO-1991005795-A1 | STEM CELL FACTOR | AMGEN INC. (US) | 1991-05-02 | — | — | WO | disclosed |
| EP-0414870-A1 | NITRATE REDUCTASE AS MARKER FOR FILAMENTOUS FUNGI | GLAXO GROUP LIMITED (GB) | 1991-03-06 | — | — | EP | disclosed |
| WO-1990010074-A1 | NITRATE REDUCTASE AS MARKER FOR FILAMENTOUS FUNGI | GLAXO GROUP LIMITED (GB) | 1990-09-07 | — | — | WO | disclosed |
| EP-0163573-B1 | SITE-SPECIFIC PROTEOLYSIS BY RENIN | MERCK & CO. INC. (US) | 1989-09-06 | — | — | EP | disclosed |
| EP-0034307-B1 | METHOD FOR THE PRODUCTION OF HUMAN LEUCOZYTE INTERFERON | HOECHST AKTIENGESELLSCHAFT (DE) | 1987-04-08 | — | — | EP | disclosed |